2 months Edwards Lifesciences (NYSE:EW) Issues Q4 Earnings Guidance MarketBeat
Edwards Lifesciences (NYSE:EW) updated its fourth quarter earnings guidance. The company provided EPS guidance of $0.53-$0.57 for the period, compared to the consensus estimate of $0.62. The company also issued revenue guidance of $1.33-$1.39 billion…
Earnings · Edwards Lifesciences (EW) · NYSE
X